Chiara Bonini

University of Rome Tor Vergata — Italy

Medicine · Health Sciences

69h-index20.5kcitations402works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(184), Hematopoietic Stem Cell Transplantation(119), Virus-based gene therapy research(106), Immune Cell Function and Interaction(95), T-cell and B-cell Immunology(59)

Publications400 total

Early unresectable relapse after hepatic resection for colorectal liver metastases: a focus on time to surgical failure
Updates in Surgery·2025
Gene transfer and genome editing of T cells for cancer immunotherapy: from allogeneic HSCT to TCR gene editing
Hematology·2025Open Access
250 Umbilical cord blood-derived CD19-CAR-T cells exhibit effective anti-tumor activity and demonstrate a low profile of pro-inflammatory and allograft rejection
Regular and Young Investigator Award Abstracts·2025Open Access
CAR19 EngTregs offer broad capacity to modulate immune tolerance and improve safety in B and T cell mediated autoimmune disorders 3850
The Journal of Immunology·2025Open Access
Fully Depleted MAPS in 110 nm CIS Technology for Particle Tracking and X-Ray Detection
2025
Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
HemaSphere·2025Open Access
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe
Cytotherapy·2025Open Access
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era
Haematologica·2025· 1 citedOpen Access
Beyond conventional adoptive T-cell therapy
Journal of Allergy and Clinical Immunology·2025Open Access
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome
Frontiers in Immunology·2025· 2 citedOpen Access
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort
Frontiers in Medicine·2025· 1 citedOpen Access
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs
Frontiers in Immunology·2025· 1 citedOpen Access
Grasping Problems at the Nanoscale: Predicting the TCR Peptide Binding in T Cell Therapy for Cancer
2025Open Access
342 | ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T‐CELLS THERAPY IS EFFECTIVE IN SECONDARY CNS LYMPHOMA REFRACTORY TO HIGH‐DOSE METHOTREXATE‐BASED CHEMOTHERAPY
Hematological Oncology·2025Open Access
P-22: GENERATION OF T CELL RECEPTOR TRANSGENIC REGULATORY T CELLS FOR ADOPTIVE THERAPY IN TYPE 1 DIABETES
Transplantation·2025
ABS0179 UNDERSTANDING CAR-TREG PERSISTENCE AND EXPANSION PROTOCOLS OPTIMIZATION
Annals of the Rheumatic Diseases·2025Open Access
ABS0653 VALIDATION OF “CLINICAL RED FLAGS” FOR RA-ILD IN AN ITALIAN COHORT: THE ROLE OF DYSPNEA, COUGH AND CRACKLES
Annals of the Rheumatic Diseases·2025Open Access
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases
Science Translational Medicine·2025· 3 cited
Abstract LB361: CD39 disruption boosts TCR-edited T cells by metabolic reprogramming
Cancer Research·2025
Abstract LB027: Adoptive cell therapy with genetically engineered T cells for epithelial ovarian cancer
Cancer Research·2025
page 1 of 20Next →

Frequent Co-authors

Fabio Ciceri(27), Claudio Bordignon(22), Attilio Bondanza(18), Catia Traversari(12), Jacopo Peccatori(12), Massimo Bernardi(11), Luca Vago(10), Sarah Marktel(10), Maria Teresa Lupo Stanghellini(9), Zulma Magnani(9), Luigi Naldini(8), Katharina Fleischhauer(8), Jürgen Kuball(8), Nicolaus Kröger(8), Mohamad Mohty(8), Arnon Nagler(8), Maurilio Ponzoni(7), Silvano Rossini(7), Nicoletta Cieri(7), Raffaella Greco(7)